Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hellsing

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Atherosclerosis|October 1, 1980
Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid estersB Vessby, H Lithell, K Hellsing, et al.
Lakartidningen|February 14, 1996
[Cooperation for quality development in primary health care: the new laboratory committee will become "a long arm" of SEQLA]K Hellsing, Y Bergqvist, M Edman-Falkensson, et al.
International Journal of Sports Medicine|February 1, 1988
Biochemical changes and endocrine responses in cystic fibrosis in relation to a marathon raceJ K Stanghelle, S Maehlum, D Skyberg, et al.
Upsala Journal of Medical Sciences|January 1, 1993
A Nordic reference serum suitable for use as trueness control in the clinical routine laboratoryO Blaabjerg, P Elg, W Gerhardt, et al.
Wiener Klinische Wochenschrift. Supplementum|January 1, 1992
[Results of multicenter evaluation of reagents for determination of sodium, potassium and chloride ions using enzyme activation]V Ehrhardt, H Baadenhuijsen, S Brenna, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Atherosclerosis|October 1, 1980
Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid estersB Vessby, H Lithell, K Hellsing, et al.
Lakartidningen|February 14, 1996
[Cooperation for quality development in primary health care: the new laboratory committee will become "a long arm" of SEQLA]K Hellsing, Y Bergqvist, M Edman-Falkensson, et al.
International Journal of Sports Medicine|February 1, 1988
Biochemical changes and endocrine responses in cystic fibrosis in relation to a marathon raceJ K Stanghelle, S Maehlum, D Skyberg, et al.
Upsala Journal of Medical Sciences|January 1, 1993
A Nordic reference serum suitable for use as trueness control in the clinical routine laboratoryO Blaabjerg, P Elg, W Gerhardt, et al.
Wiener Klinische Wochenschrift. Supplementum|January 1, 1992
[Results of multicenter evaluation of reagents for determination of sodium, potassium and chloride ions using enzyme activation]V Ehrhardt, H Baadenhuijsen, S Brenna, et al.
Pageof 7